Phibro Animal Health - 10 Year Stock Price History | PAHC
- The all-time high Phibro Animal Health stock closing price was 45.79 on August 27, 2018.
- The Phibro Animal Health 52-week high stock price is 25.98, which is 9.4% above the current share price.
- The Phibro Animal Health 52-week low stock price is 9.49, which is 60% below the current share price.
- The average Phibro Animal Health stock price for the last 52 weeks is 16.46.
Phibro Animal Health Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 16.9345 | 11.5722 | 25.5500 | 10.3984 | 23.7500 | 109.66% |
2023 | 13.1519 | 12.8785 | 15.4222 | 9.3339 | 11.3277 | -10.34% |
2022 | 16.1132 | 19.0529 | 19.9762 | 11.2870 | 12.6336 | -32.33% |
2021 | 21.4922 | 17.6617 | 27.2155 | 17.3341 | 18.6689 | 7.28% |
2020 | 19.6614 | 22.1937 | 24.9333 | 14.6418 | 17.4018 | -20.11% |
2019 | 24.4779 | 27.4684 | 31.8514 | 17.7553 | 21.7814 | -21.32% |
2018 | 35.6075 | 29.2172 | 45.7883 | 26.8400 | 27.6836 | -2.99% |
2017 | 28.3653 | 24.9094 | 33.8779 | 22.0482 | 28.5358 | 15.73% |
2016 | 20.6969 | 24.1785 | 28.8734 | 14.9003 | 24.6569 | -1.17% |
2015 | 27.8458 | 25.2538 | 32.9592 | 22.3723 | 24.9486 | -3.40% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.962B | $1.018B |
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
Stryker (SYK) | United States | $148.171B | 33.39 |
Boston Scientific (BSX) | United States | $133.131B | 38.28 |
EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
Medtronic (MDT) | Ireland | $109.010B | 16.19 |
Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
ResMed (RMD) | United States | $34.955B | 28.72 |
Terumo (TRUMY) | Japan | $29.203B | 41.24 |
Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
Insulet (PODD) | United States | $18.377B | 73.18 |
Baxter (BAX) | United States | $16.604B | 10.80 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
Demant (WILYY) | Denmark | $8.342B | 0.00 |
Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
Haemonetics (HAE) | United States | $4.260B | 20.79 |
ICU Medical (ICUI) | United States | $4.155B | 39.56 |
Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
Envista Holdings (NVST) | United States | $3.487B | 25.97 |
Neogen (NEOG) | United States | $3.270B | 37.72 |
Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
Warby Parker (WRBY) | United States | $2.344B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
AtriCure (ATRC) | United States | $1.772B | 0.00 |
InMode (INMD) | Israel | $1.487B | 8.94 |
Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
Owens & Minor (OMI) | United States | $0.957B | 7.48 |
CeriBell (CBLL) | United States | $0.916B | 0.00 |
National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
Evolus (EOLS) | United States | $0.785B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
Surmodics (SRDX) | United States | $0.559B | 0.00 |
Quanterix (QTRX) | United States | $0.424B | 0.00 |
Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
Valneva SE (VALN) | France | $0.370B | 0.00 |
ZimVie (ZIMV) | United States | $0.363B | 30.63 |
Omeros (OMER) | United States | $0.349B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
Biote (BTMD) | United States | $0.330B | 7.25 |
Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
Cerus (CERS) | United States | $0.312B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
Zynex (ZYXI) | United States | $0.249B | 52.13 |
TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
MacroGenics (MGNX) | United States | $0.218B | 0.00 |
High Tide (HITI) | Canada | $0.215B | 89.00 |
Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
Jin Medical (ZJYL) | China | $0.188B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
Brainsway (BWAY) | Israel | $0.161B | 96.70 |
Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
Fonar (FONR) | United States | $0.093B | 10.54 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
Veru (VERU) | United States | $0.092B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
Modular Medical (MODD) | United States | $0.073B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
InterCure (INCR) | Israel | $0.063B | 0.00 |
Exagen (XGN) | United States | $0.062B | 0.00 |
MariMed (MRMD) | United States | $0.059B | 0.00 |
Safety Shot (SHOT) | United States | $0.056B | 0.00 |
Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
Apyx Medical (APYX) | United States | $0.048B | 0.00 |
ImmuCell (ICCC) | United States | $0.032B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 13.17 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |